SREBF chaperone anticorps (Middle Region)
Aperçu rapide pour SREBF chaperone anticorps (Middle Region) (ABIN453817)
Antigène
Voir toutes SREBF chaperone (SCAP) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- This antibody reacts to SCAP.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide selected from the Center region of human SCAP
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SREBF chaperone (SCAP)
-
Autre désignation
- SCAP
-
Sujet
- SCAP is a protein with a sterol sensing domain(SSD) and seven WD domains. In the presence of cholesterol, this protein binds to sterol regulatory element binding proteins (SREBPs) and mediates their transport from the ER to the Golgi. The SREBPs are then proteolytically cleaved and regulate sterol biosynthesis.Synonyms: KIAA0199, SREBP cleavage-activating protein, Sterol regulatory element-binding protein cleavage-activating protein
-
ID gène
- 22937
-
NCBI Accession
- NP_036367
-
UniProt
- Q12770
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-